SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Dr. Sean McCarthy, PhD, will speak at the Duke Beijing Healthcare Forum.
News | 05. 26. 2007
